» Articles » PMID: 38806057

Distinctive Multicellular Immunosuppressive Hubs Confer Different Intervention Strategies for Left- and Right-sided Colon Cancers

Overview
Journal Cell Rep Med
Publisher Cell Press
Date 2024 May 28
PMID 38806057
Authors
Affiliations
Soon will be listed here.
Abstract

Primary colon cancers arising from the left and right sides exhibit distinct clinical and molecular characteristics. Sidedness-associated heterogeneity relies intricately on the oncogenic properties of cancer cells and multicellular interactions in tumor microenvironments. Here, combining transcriptomic profiling of 426,863 single cells from 105 colon cancer patients and validation with spatial transcriptomics and large-scale histological analysis, we capture common transcriptional heterogeneity patterns between left- and right-sided malignant epithelia through delineating two side-specific expression meta-programs. The proliferation stemness meta-program is notably enriched in left-sided malignant epithelia that colocalize with Mph-PLTP cells, activated regulatory T cells (Tregs), and exhausted CD8-LAYN cells, constituting the glucose metabolism reprogramming niche. The immune secretory (IS) meta-program exhibits specific enrichment in right-sided malignant epithelia, especially in smoking patients with right-sided colon cancer. The IS malignant epithelia spatially localize in hypoxic regions and facilitate immune evasion through attenuating Mph-SPP1 cell antigen presentation and recruiting innate-like cytotoxicity-reduced CD8-CD161 cells.

Citing Articles

LncRNA is correlated with prognosis and immune infiltration and facilitates tumor progression by targeting in colorectal cancer.

Chen T, Jiang Q, Wang Z, Wang F, Fu Z Transl Cancer Res. 2024; 13(10):5347-5364.

PMID: 39525019 PMC: 11543043. DOI: 10.21037/tcr-24-378.

References
1.
Seferbekova Z, Lomakin A, Yates L, Gerstung M . Spatial biology of cancer evolution. Nat Rev Genet. 2022; 24(5):295-313. DOI: 10.1038/s41576-022-00553-x. View

2.
Ruf B, Greten T, Korangy F . Innate lymphoid cells and innate-like T cells in cancer - at the crossroads of innate and adaptive immunity. Nat Rev Cancer. 2023; 23(6):351-371. DOI: 10.1038/s41568-023-00562-w. View

3.
Pedersen L, Idorn M, Olofsson G, Lauenborg B, Nookaew I, Hansen R . Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution. Cell Metab. 2016; 23(3):554-62. DOI: 10.1016/j.cmet.2016.01.011. View

4.
Joanito I, Wirapati P, Zhao N, Nawaz Z, Yeo G, Lee F . Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer. Nat Genet. 2022; 54(7):963-975. PMC: 9279158. DOI: 10.1038/s41588-022-01100-4. View

5.
Gu A, Zhang S, Wang Y, Xiong H, Curtis T, Wan Y . A critical role for transcription factor Smad4 in T cell function that is independent of transforming growth factor β receptor signaling. Immunity. 2015; 42(1):68-79. PMC: 4303504. DOI: 10.1016/j.immuni.2014.12.019. View